Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Sanofi SA    SNY

Delayed Quote. Delayed  - 05/03 04:17:35 pm
41.32 USD   -0.34%
02:14p MEDIVATION : Board rejects Sanofi’s unsolicited proposal
05/02 SANOFI : Comments on Medivation's Rejection of acquisition Proposal
05/01 BRIEF : Sanofi girds for another fight
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 115 631 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmacy36,62882.1%32,88886.3% -10.21%
Vaccines5,25111.8%5,23513.7% -0.31%
Animal Health2,7436.1%---
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
Other Countries15,13333.9%13,05634.2% -13.73%
United States14,98333.6%13,51535.5% -9.79%
Europe10,48123.5%8,40222% -19.83%
France3,2697.3%2,4816.5% -24.1%
North America755.811.7%667.711.8% -11.66%
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD602015Chief Executive Officer & Director
Serge Weinberg652009Chairman
Jérôme Contamine592009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD652011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Robert Castaigne, PhD702000Independent Director
Jean-René Fourtou772004Independent Director
Claudie Haigneré MD, PhD592008Independent Director
Uwe Bicker MD, PhD712008Independent Director
Carole Piwnica582010Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,305,696,759 1,166,815,695 89.4% 3,956,708 0.3% 89.4%
Shareholders
NameEquities%
Dodge & Cox 49,915,073 1.91%
Barrow, Hanley, Mewhinney & Strauss LLC 29,489,368 1.13%
Franklin Advisers, Inc. 18,292,201 0.70%
Fisher Asset Management LLC 13,546,950 0.52%
Fidelity Management & Research Co. 10,798,293 0.41%
Hotchkis & Wiley Capital Management LLC 10,141,383 0.39%
Invesco Advisers, Inc. 6,948,033 0.27%
Harris Associates LP 5,775,040 0.22%
Berkshire Hathaway, Inc. (Investment Management) 3,905,875 0.15%
Delaware Management Business Trust 3,741,814 0.14%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,353,66522.7%8,417,595,013 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%840,151,852 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.0%643,808,853 USD
Sanofi (SAN) 3,956,7080.30%319,498,276 USD
Zentiva SA (ROSCD) 312,341,64974.9%144,148,794 USD
Myokardia Inc (MYOK) 3,218,89911.9%34,474,408 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.26%21,632,425 USD
Immune Design Corp (IMDZ) 917,4294.55%11,926,577 USD
Proteome Sciences plc (PRM) 38,0000.017%8,466 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 500.0001%1,155 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
BRISTOL-MYERS SQU..
NOVO NORDISK A/S
SANOFI
GLAXOSMITHKLINE P..
BAYER AG
ALLERGAN PLC
ELI LILLY AND CO
ASTRAZENECA PLC
ABBOTT LABORATORI..
TEVA PHARMACEUTIC..
-
TAKEDA PHARMACEUT..
SHIRE PLC
ASTELLAS PHARMA I..
MYLAN NV
CHUGAI PHARMACEUT..
Sector Pharmaceuticals
Sanofi SA : Connections
Fondation de France
The Children's Aid Society, Inc.
Madrigall SA
Academie de l'air et de l'espace
Bordeaux University Foundation
Fondation pour l’Université de Lyon
Council on Foreign Relations, Inc.
Pharmaceutical Research & Manufacturers of America
Sanofi-Aventis Europe SAS
Financière Piasa SAS
Sanofi-Aventis Participations SA
Pres héSam
Académie des Technologies
Financières SASA
Philipps University of Marburg
Sanofi Pasteur Holding SA
Naxos UK Ltd.
Sanofi Pasteur Holding & Merial Ltd.
Piasa SA
Weinberg Capital Partners SAS
Sanofi-Aventis U.S. LLC
International Federation of Pharmaceutical Manufacturers A
Alliance Automotive Group SAS
National Committee on United States-China Relations, Inc.
Research!America
Fondation C.Génial
King Abdullah University of Science & Technology
Fondation Lacoste
Maremma SASU
L'Oréal Corporate Foundation
Big Red, Inc.
Academie des Sports
RecyCoal Ltd.
Académie des Sciences et Technologies
Paris Bar Association
Aventis Foundation
Montres CORUM Sàrl
Ruprecht-Karls-Universität Heidelberg
MedImmune LLC
i2O Water Ltd.
Piasa Holding SAS
Elevance Renewable Sciences, Inc.
Warp Drive Bio LLC
Académie Nationale de Médecine
National Academy of Engineering
Select Music & Video Distribution Ltd.
Institute of Medicine
New York State Bar Association
The Johns Hopkins University
NAXOS Capital Managers SARL
Company contact information
Sanofi
54, rue La Boétie
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.44.63
Web : www.sanofi.com
© 2016 People , Fundamentals and Ownership